Allogene Therapeutics Inc (ALLO)
SG&A Expense Growth
47.91%
Quarterly · Period ending:
ALLO SG&A Expense Growth
Latest reported47.91%period ending
Latest reported47.91%period ending
ALLO Quarterly SG&A Growth (QoQ) (0.00% → 47.91%)
Latest values, visible window
High-resolution chart · PNG
ALLO sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 47.9097% | |
| 2.3018% | |
| 0.2548% | |
| -3.8093% | |
| -4.7362% | |
| -3.3961% | |
| -4.9899% | |
| 1.5292% | |
| -6.8338% | |
| 0.2497% | |
| 1.0739% | |
| -8.0058% | |
| -1.9064% | |
| -10.0848% | |
| 11.1393% | |
| -3.137% | |
| -1.95% | |
| -0.3206% | |
| 5.0634% | |
| 1.15% | |
| 14.7895% | |
| -4.4998% | |
| 3.0989% | |
| 4.7724% | |
| 1.413% | |
| 2.8201% | |
| 1.3053% | |
| 5.8434% | |
| 8.646% | |
| -10.2049% | |
| 28.497% | |
| -9.6519% | |
| 382.3258% | |
| 129,750% | |
| 0% |